| 生物活性 | |||
|---|---|---|---|
| 靶点 | 
 | ||
| 描述 | Amprenavir is a selective HIV protease inhibitor with a Ki value of 0.6nM. The IC50 value of amprenavir against wild-type clinical HIV isolates in vitro is 14.6 ± 12.5ng/mL.[3] Treatment of Huh-7 cells with amprenavir (50μM) significantly inhibited invasion, blocked the conversion of latent MMP-2 to its 62/64-kD active form, but had no effect on cell proliferation compared to the DMSO-treated controls. Treatment with amprenavir via intragastric gavage (60 mg/kg/d, 5 days/week) for 3 weeks delayed tumor growth in nude mice inoculated with hepatoma Huh-7 cells.[4] | ||
| 作用机制 | Amprenavir prevents the virally encoded HIV protease from processing the cleavage of its natural substrates, gag and gag-pol polyproteins. It exerts the antiretroviral effect late in the HIV life cycle by interfering with virion maturation.[3] | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 1.98mL 0.40mL 0.20mL | 9.89mL 1.98mL 0.99mL | 19.78mL 3.96mL 1.98mL | 
| 参考文献 | 
|---|